-
1
-
-
0036009352
-
Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumours
-
Tsatalpas P., Beuthien-Baumann B., Kropp J., et al. Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumours. Urol Int 68 (2002) 157-163
-
(2002)
Urol Int
, vol.68
, pp. 157-163
-
-
Tsatalpas, P.1
Beuthien-Baumann, B.2
Kropp, J.3
-
2
-
-
0036343610
-
The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours
-
Spermon J., De-Geus-Oei L., Kiemeney L., Witjes J., and Oyen W. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours. BJU Int 89 (2002) 549-556
-
(2002)
BJU Int
, vol.89
, pp. 549-556
-
-
Spermon, J.1
De-Geus-Oei, L.2
Kiemeney, L.3
Witjes, J.4
Oyen, W.5
-
3
-
-
28844468964
-
Nuclear medicine studies of the prostate, testes and bladder
-
Jana S., and Blaufox M. Nuclear medicine studies of the prostate, testes and bladder. Semin Nucl Med 36 (2006) 51-72
-
(2006)
Semin Nucl Med
, vol.36
, pp. 51-72
-
-
Jana, S.1
Blaufox, M.2
-
4
-
-
0037870111
-
Clinical role of FDG PET in evaluation of cancer patients
-
Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23 (2003) 315-340
-
(2003)
Radiographics
, vol.23
, pp. 315-340
-
-
-
5
-
-
1642387843
-
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging
-
Cook G., Wegner E., and Fogelman I. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med 34 (2004) 122-133
-
(2004)
Semin Nucl Med
, vol.34
, pp. 122-133
-
-
Cook, G.1
Wegner, E.2
Fogelman, I.3
-
6
-
-
0031967456
-
FDG PET for detection and therapy control of metastatic germ cell tumour
-
Cremerius U., Effert P., Adam G., et al. FDG PET for detection and therapy control of metastatic germ cell tumour. J Nucl Med 39 (1998) 815-822
-
(1998)
J Nucl Med
, vol.39
, pp. 815-822
-
-
Cremerius, U.1
Effert, P.2
Adam, G.3
-
7
-
-
0033826384
-
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
-
Hain S., O'Doherty M., Timothy A., Leslie M., Harper P., and Huddart R. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer 83 (2000) 863-869
-
(2000)
Br J Cancer
, vol.83
, pp. 863-869
-
-
Hain, S.1
O'Doherty, M.2
Timothy, A.3
Leslie, M.4
Harper, P.5
Huddart, R.6
-
8
-
-
23044447727
-
Whole body PET/CT: spectrum of physiological variants, artefacts and interpretative pitfalls in cancer patients
-
Gorospe L., Raman S., Echeveste J., et al. Whole body PET/CT: spectrum of physiological variants, artefacts and interpretative pitfalls in cancer patients. Nucl Med Commun 26 (2005) 671-687
-
(2005)
Nucl Med Commun
, vol.26
, pp. 671-687
-
-
Gorospe, L.1
Raman, S.2
Echeveste, J.3
-
9
-
-
33645389295
-
PET in abdominal pathology: advantages and limitations
-
Salmon A.S., Salgado J.B., and Morell A.R. PET in abdominal pathology: advantages and limitations. Abdom Imaging 31 (2006) 174-181
-
(2006)
Abdom Imaging
, vol.31
, pp. 174-181
-
-
Salmon, A.S.1
Salgado, J.B.2
Morell, A.R.3
-
10
-
-
1842736053
-
False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET-radiological-pathological correlation
-
Shiraki N., Hara M., Ogino H., et al. False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET-radiological-pathological correlation. Ann Nucl Med 18 (2004) 23-28
-
(2004)
Ann Nucl Med
, vol.18
, pp. 23-28
-
-
Shiraki, N.1
Hara, M.2
Ogino, H.3
-
12
-
-
0036209768
-
FDG-PET as a metabolic biopsy tool in non-lung lesions with indeterminate biopsy
-
Beggs A., Hain S., Curran K., and O'Doherty M. FDG-PET as a metabolic biopsy tool in non-lung lesions with indeterminate biopsy. Eur J Nucl Med 29 (2002) 542-546
-
(2002)
Eur J Nucl Med
, vol.29
, pp. 542-546
-
-
Beggs, A.1
Hain, S.2
Curran, K.3
O'Doherty, M.4
|